Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Self-Adjusted Nitrous Oxide in Vasectomy
NCT05895383Phase 4Recruiting
- Sponsor
- Beth Israel Deaconess Medical Center
- Start
- May 2023
- Primary completion
- Jan 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of nitrous oxide in procedural pain and Procedural anxiety, sponsored by Beth Israel Deaconess Medical Center. Primary endpoint: Procedural pain assessed by the Visual Analog Scale for Pain (VAS-P) at 0 weeks. Started May 2023; status: recruiting.
02
Drugs
nitrous oxide
03
Conditions
procedural painProcedural anxiety
Beyond the preview
Go deeper on NCT05895383.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05895383.